farnesol has been researched along with Moniliasis, Oral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Duan, W; Huang, R; Li, C; Liu, S; Wei, X; Xu, Z | 1 |
Abe, S; Funakoshi, K; Hisajima, T; Ishibashi, H; Makimura, K; Maruyama, N; Nishiyama, Y; Oshima, H; Tanabe, Y; Yamada, T | 1 |
Luitaud, C; Rouabhia, M; Saidi, S | 1 |
3 other study(ies) available for farnesol and Moniliasis, Oral
Article | Year |
---|---|
Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Farnesol; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pharmaceutical Preparations | 2021 |
Protective effects of farnesol against oral candidiasis in mice.
Topics: Animals; Antifungal Agents; Body Weight; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Dose-Response Relationship, Drug; Farnesol; Feces; Female; Kidney; Liver; Mice; Mice, Inbred ICR; Mycelium; Severity of Illness Index; Tongue | 2008 |
In vitro synergistic effect of farnesol and human gingival cells against Candida albicans.
Topics: Candida albicans; Candidiasis, Oral; Cell Adhesion; Cell Proliferation; Cells, Cultured; Epithelial Cells; Farnesol; Fibroblasts; Gingiva; Humans; Mouth Diseases | 2006 |